RUXOLITINIB (RUXOLITINIB PHOSPHATE) — all Canadian products
5 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is RUXOLITINIB (RUXOLITINIB PHOSPHATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02388006 | JAKAVI | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | RUXOLITINIB (RUXOLITINIB PHOSPHATE) 5 MG | Marketed | |
| 02388014 | JAKAVI | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | RUXOLITINIB (RUXOLITINIB PHOSPHATE) 15 MG | Marketed | |
| 02388022 | JAKAVI | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | RUXOLITINIB (RUXOLITINIB PHOSPHATE) 20 MG | Marketed | |
| 02434814 | JAKAVI | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | RUXOLITINIB (RUXOLITINIB PHOSPHATE) 10 MG | Marketed | |
| 02552434 | OPZELURA | INCYTE CORPORATION | Cream | Topical | RUXOLITINIB (RUXOLITINIB PHOSPHATE) 1.5 % | Marketed |
Browse other molecules: